ARCHIVES

$14.7 Million Earmark Of NCI funds Trigger Protest By Advocates, Scientists

This article is from The Cancer Letter archive.

Vol. 22 No. 41 | October 24, 1996

Download PDF Visit The Full Archive

Related Articles

DCPC Board Okays Start of Low Fat High Risk Breast Cancer Study, Delays Stage 2 Trial

February 1, 1985

Review Group Report: NCI Role In Drug Development Seen As Information Provider

November 6, 1998

FDA, NCI Seek Compromise On Survival Endpoints

June 16, 1989

NCCN Launches Outcomes Improvement Program

August 12, 2011

NSABP Protests NIH Rejection Of P-4 Appeal.

May 2, 2008

Final Issue of 1981

December 11, 1981